MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of investments
$35,000K
Proceeds from issuance of
common stock
$14,021K
Net cash provided by
investing activities
$34,983K
Net cash provided by
(used in) financing...
$1,209K
Canceled cashflow
$17K
Canceled cashflow
$12,812K
Net increase
(decrease) in cash and cash...
$10,273K
Canceled cashflow
$25,919K
Purchases of property and
equipment
$17K
Non-cash interest
expense for sale of...
$20,859K
Stock-based compensation
$14,218K
Receivables from
collaborative partners
-$8,103K
Prepaid expenses and
other assets
-$1,501K
Amortization of right-of-use
assets operating
$480K
Depreciation and
amortization
$130K
Principal repayment of
liability for sale of...
$12,812K
Net cash used in
operating activities
-$25,919K
Canceled cashflow
$45,291K
Net loss
-$52,884K
Accounts payable and
other liabilities
-$17,819K
Operating lease
liabilities
-$499K
Accretion/amortization of investments,
net
$8K
Back
Back
Cash Flow
ANAPTYSBIO, INC (ANAB)
ANAPTYSBIO, INC (ANAB)
source: myfinsight.com